Series B - Palladio Biosciences

Series B - Palladio Biosciences

Investment Firm

Overview

Palladio Biosciences develops transformative medicines for orphan diseases of the kidney.

Announced Date

Sep 25, 2020

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

3

Investor Name
Participant InvestorMedicxi
Participant InvestorRoche Venture Fund
Participant InvestorOUP (Osage University Partners)

Round Details and Background

Palladio Biosciences raised $20000000 on 2020-09-25 in Series B

Palladio Biosciences develops transformative medicines for orphan diseases of the kidney.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 23, 2017
Series A - Palladio Biosciences
1-undefined
Sep 25, 2020
Series B - Palladio Biosciences
4-20.0M

Recent Activity

There is no recent news or activity for this profile.